These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3110845)

  • 21. Vasopressin(1-8) (des-glycinamide9-[Arg8]vasopressin) is an endogenous peptide present in rat plasma.
    Laczi F; Burbach JP; Van der Kleij AA; De Wied D; Wiegant VM
    Peptides; 1991; 12(2):329-32. PubMed ID: 2067985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of (DesGly9-Arg8) vasopressin on cognitive processes in alcoholic patients.
    Korsić M; Jokić N; Ilić-Supek D; Skocilić Z; Lovrić M; Bacić J; Jakovljević M; Maslo K; Trbović M
    Acta Med Iugosl; 1991; 45(3):223-9. PubMed ID: 1950641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on desglycinamide arginine vasopressin and scopolamine in a modified/lever-touch autoshaping model of learning/memory in rats.
    Mundy WR; Iwamoto ET
    Pharmacol Biochem Behav; 1987 Jun; 27(2):307-15. PubMed ID: 3628445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of a trimethyltin-induced learning deficit by desglycinamide-8-arginine vasopressin.
    Sparber SB; Cohen CA; Messing RB
    Life Sci; 1988; 42(2):171-7. PubMed ID: 3336276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin-like peptides retain ethanol tolerance in the absence of changes in serotonin synthesis in limbic structures.
    Speisky MB; Kalant H
    Pharmacol Biochem Behav; 1986 Oct; 25(4):797-803. PubMed ID: 2431418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the influence of vasopressin neuropeptides on social recognition of rats.
    Sekiguchi R; Wolterink G; van Ree JM
    Eur Neuropsychopharmacol; 1991 May; 1(2):123-6. PubMed ID: 1821701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin and ACTH analogs affect orienting but not activity in rabbits.
    Hernandez LL
    Peptides; 1985; 6 Suppl 2():97-101. PubMed ID: 3001676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Des-Gly9-[Arg8]-vasopressin may facilitate methadone detoxification of heroin addicts.
    van Beek-Verbeek G; Fraenkel HM; van Ree JM
    Subst Alcohol Actions Misuse; 1983; 4(5):375-82. PubMed ID: 6670060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a single dose of des-glycinamide-[Arg8]vasopressin or oxytocin on cognitive processes in young healthy subjects.
    Bruins J; Hijman R; Van Ree JM
    Peptides; 1992; 13(3):461-8. PubMed ID: 1523161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoassay of desglycinamide-arginine vasopressin and its application in a pharmacokinetic study in the rat.
    van Bree JB; de Boer AG; Danhof M; Verhoef JC; van Wimersma Greidanus TB; Breimer DD
    Peptides; 1988; 9(3):555-9. PubMed ID: 3420013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of desglycinamide-arginine-vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and non-diabetic subjects.
    Laczi F; van Ree JM; Wagner A; Valkusz Z; Járdánházy T; Kovács GL; Telegdy G; Szilárd J; László FA; de Wied D
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):205-12. PubMed ID: 6829260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology.
    van Bree JB; Tio S; de Boer AG; Danhof M; Verhoef JC; Breimer DD
    Pharm Res; 1990 Mar; 7(3):293-8. PubMed ID: 2339105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social transmission of flavored tea preferences: facilitation by a vasopressin analog and oxytocin.
    Popik P; Van Ree JM
    Behav Neural Biol; 1993 Jan; 59(1):63-8. PubMed ID: 8442734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial.
    Wolters EC; Riekkinen P; Lowenthal A; Van der Plaats JJ; Zwart JM; Sennef C
    Neurology; 1990 Jul; 40(7):1099-101. PubMed ID: 2192301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of vasopressin on memory in the healthy elderly.
    Nebes RD; Reynolds CF; Horn LC
    Psychiatry Res; 1984 Jan; 11(1):49-59. PubMed ID: 6584931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in cognitively impaired patients.
    Tinklenberg JR; Pigache R; Berger PA; Kopell BS
    Psychopharmacol Bull; 1982 Oct; 18(4):202-4. PubMed ID: 7156291
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of specific antisera against 9-desglycinamide-8-arginine vasopressin by site-specific immunization.
    van Bree JB; van Nispen JW; Verhoef JC; Breimer DD
    J Pharm Sci; 1991 Jan; 80(1):46-9. PubMed ID: 2013849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Greater task difficulty amplifies the facilitatory effect of des-glycinamide arginine vasopressin on appetitively motivated learning.
    Messing RB; Sparber SB
    Behav Neurosci; 1985 Dec; 99(6):1114-9. PubMed ID: 3843542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of DGAVP and Org2766 on intracellular free Ca2+ concentration in dissociated brain cells].
    Zhang WN; Wu FM; Zhang ZX; Xiao XS; Zhang Y; Wang JX; Chen RS
    Yao Xue Xue Bao; 1993; 28(9):655-60. PubMed ID: 8010010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.